Some institutions use peripheral blood measurements of chromogranin A (CgA) and neuron specific enolase (NSE) as these have been shown to be elevated in some patients with high grade neuroendocrine carcinoma including SCLC and some LCNEC patients (74). This evidence concerns the gene CHGA and large cell neuroendocrine carcinoma.